HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor Therapy under Hypoxic Microenvironment by the Combination of 2-Methoxyestradiol and Sodium Dichloroacetate on Human Non-Small-Cell Lung Cancer.

Abstract
A hypoxic microenvironment is a hallmark in different types of tumors; this phenomenon participates in a metabolic alteration that confers resistance to treatments. Because of this, it was proposed that a combination of 2-methoxyestradiol (2-ME) and sodium dichloroacetate (DCA) could reduce this alteration, preventing proliferation through the reactivation of aerobic metabolism in lung adenocarcinoma cell line (A549). A549 cells were cultured in a hypoxic chamber at 1% O2 for 72 hours to determine the effect of this combination on growth, migration, and expression of hypoxia-inducible factors (HIFs) by immunofluorescence. The effect in the metabolism was evaluated by the determination of glucose/glutamine consumption and the lactate/glutamate production. The treatment of 2-ME (10 μM) in combination with DCA (40 mM) under hypoxic conditions showed an inhibitory effect on growth and migration. Notably, this reduction could be attributed to 2-ME, while DCA had a predominant effect on metabolic activity. Moreover, this combination decreases the signaling of HIF-3α and partially HIF-1α but not HIF-2α. The results of this study highlight the antitumor activity of the combination of 2-ME 10 μl/DCA 40 mM, even in hypoxic conditions.
AuthorsYair Romero, Manuel Castillejos-López, Susana Romero-García, Alfonso Salgado Aguayo, Iliana Herrera, Misael O Garcia-Martin, Luz Maria Torres-Espíndola, Maria Cristina Negrete-García, Angel Camarena Olvera, Juan Carlos Huerta-Cruz, Rafael Velazquez Cruz, José Cisneros, Edgar Flores Soto, Héctor Solís-Chagoyán, Criselda Mendoza-Milla, Carlos Cabello-Gutiérrez, Víctor Ruiz, Arnoldo Aquino-Gálvez
JournalOxidative medicine and cellular longevity (Oxid Med Cell Longev) Vol. 2020 Pg. 3176375 ( 2020) ISSN: 1942-0994 [Electronic] United States
PMID33149807 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Yair Romero et al.
Chemical References
  • Antineoplastic Agents
  • Apoptosis Regulatory Proteins
  • Basic Helix-Loop-Helix Transcription Factors
  • HIF3A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Repressor Proteins
  • Glutamine
  • endothelial PAS domain-containing protein 1
  • Lactic Acid
  • Glutamic Acid
  • 2-Methoxyestradiol
  • Dichloroacetic Acid
  • Glucose
Topics
  • 2-Methoxyestradiol (pharmacology, therapeutic use)
  • A549 Cells
  • Antineoplastic Agents (pharmacology)
  • Antineoplastic Combined Chemotherapy Protocols (pharmacology, therapeutic use)
  • Apoptosis Regulatory Proteins (metabolism)
  • Basic Helix-Loop-Helix Transcription Factors (metabolism)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, pathology)
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Dichloroacetic Acid (pharmacology, therapeutic use)
  • Glucose (metabolism)
  • Glutamic Acid (metabolism)
  • Glutamine (metabolism)
  • Glycolysis (drug effects)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Lactic Acid (metabolism)
  • Lung Neoplasms (drug therapy, pathology)
  • Repressor Proteins (metabolism)
  • Signal Transduction (drug effects)
  • Tumor Hypoxia (drug effects)
  • Tumor Microenvironment (drug effects)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: